繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

美敦力糖尿病部门MiniMed申请IPO

2025-12-20 05:30

  • Medtronic plc (MDT) announced that its diabetes business, to operate as MiniMed, has filed a Form S-1 registration statement with the SEC for a proposed initial public offering.
  • The separation is expected to be completed through capital markets transactions, with a preferred path of an IPO followed by a split-off.
  • MiniMed plans to list its common stock on the Nasdaq Global Select Market under the ticker symbol "MMED".
  • The number of shares to be offered and the IPO price range have not yet been determined.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。